| Yazarlar |
İrem Ceren Erbaş
Dokuz Eylül Üniversitesi, Turkey |
|
Yıldız Ekemen Keleş
Tepecik Training and Research Hospital, Turkey |
|
Emine Hafize Erdeniz
Ondokuz Mayis Üniversitesi, Turkey |
Doç. Dr. Ayşe YILMAZ
Kastamonu Üniversitesi, Türkiye |
|
Edanur Yeşil
T. C. Sağlık Bakanlığı, Mersin Devlet Hastanesi, Turkey |
|
Özlem Çakıcı
Kocaeli Üniversitesi, Turkey |
|
Mehtap Akça
Mersin Üniversitesi, Turkey |
|
Nursel Kara Ulu
Gazi University, Faculty of Medicine, Turkey |
|
Fatih Dinç
Dokuz Eylül Üniversitesi, Turkey |
|
Dilek Yılmaz Çiftdoğan
Tepecik Training and Research Hospital, Turkey |
|
Selim Öncel
Kocaeli Üniversitesi, Turkey |
|
Necdet Kuyucu
Mersin Üniversitesi, Turkey |
|
Anıl Tapısız
Gazi University, Faculty of Medicine, Turkey |
|
Nurşen Belet
Dokuz Eylül Üniversitesi, Turkey |
| Özet |
| Background: Although it was originally unknown whether there would be cases of reinfection of coronavirus disease 2019 (COVID-19) as seen with other coronaviruses, cases of reinfection were reported from various regions recently. However, there is little information about reinfection in children. Methods: In this study, we aimed to investigate the incidence and clinical findings of reinfection in pediatric patients who had recovered from COVID-19. We retrospectively evaluated all patients under 18 years of age with COVID-19 infection from a total of eight healthcare facilities in Turkey, between March 2020 and July 2021. Possible reinfection was defined as a record of confirmed COVID-19 infection based on positive reverse transcription-polymerase chain reaction (RT-PCR) test results at least 3 months apart. Results: A possible reinfection was detected in 11 out of 8840 children, which yielded an incidence of 0.12%. The median duration between two episodes of COVID-19 was 196 (92–483) days. When initial and second episodes were compared, the rates of symptomatic and asymptomatic disease were similar for both, as was the severity of the disease (p = 1.000). Also, there was no significant difference in duration of symptoms (p = 0.498) or in hospitalization rates (p = 1.000). Only one patient died 15 days after PCR positivity, which resulted in a 9.1% mortality rate for cases of reinfection in pediatric patients. Conclusion: We observed that children with COVID-19 were less likely to be exposed to reinfection when compared with adults. Although the clinical spectrum of reinfection was mostly similar to the first episode, we reported death of a healthy child during the reinfection. |
| Anahtar Kelimeler |
| Children | COVID-19 | Pediatrics | Reinfection | SARS-CoV-2 |
| Makale Türü | Özgün Makale |
| Makale Alt Türü | SSCI, AHCI, SCI, SCI-Exp dergilerinde yayımlanan tam makale |
| Dergi Adı | Archives de Pediatrie |
| Dergi ISSN | 0929-693X |
| Dergi Grubu | Q3 |
| Makale Dili | İngilizce |
| Basım Tarihi | 04-2023 |
| Cilt No | 30 |
| Sayı | 3 |
| Sayfalar | 187 / 191 |
| Doi Numarası | 10.1016/j.arcped.2023.01.008 |
| Atıf Sayıları | |
| SCOPUS | 4 |
